StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $5.75 | $5.66 | -1.57% | 0.0M |
| 05-12 | $5.63 | $5.62 | -0.18% | 0.0M |
| 05-13 | $5.56 | $5.50 | -1.08% | 0.1M |
| 05-14 | $5.52 | $5.50 | -0.36% | 0.0M |
| 05-15 | $5.52 | $5.44 | -1.45% | 0.0M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $128.16M | $68.89M | $344.50M | $83.34M |
Operating Income | $1.38M | $1.44M | $16.79M | $3.75M |
Net Income | $-3.86M | $-1.32M | $1.36M | $289.00K |
EPS (Diluted) | $-0.27 | $-0.09 | $0.09 | $0.02 |
Total Assets | $276.71M | $283.51M | $290.66M | $299.34M |
Total Liabilities | $166.44M | $171.32M | $177.71M | $185.64M |
Cash & Equivalents | $131.00K | $257.00K | $125.00K | $194.00K |
Free Cash Flow OCF − CapEx | $-1.02M | $-4.81M | $22.98M | $12.32M |
Shares Outstanding | 14.49M | 14.49M | 14.49M | 14.39M |
DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.